Last Price$8.511.2%
Market Cap$1,347.5M
(375.6%)
Industry median - (169.7%)
5Y Historical average - (291.4%)
(386.0%)
Industry median - (172.9%)
5Y Historical average - (299.5%)
(58.0%)
Industry median - (41.2%)
5Y Historical average - (760.2%)
(39.3%)
Industry median - (39.5%)
5Y Historical average - (57.6%)
OCUL Capital Allocation Rating
OCUL Capital Allocation rating
4.9
OCUL Capital Allocation rating performance
OCUL Capital Allocation metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with OCUL Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$1,347.5M | 4.9 | (375.6%) | (386.0%) | (298.9%) | (58.0%) | (39.3%) | 97.8% | N/A | |
$124.8B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$77.0B | 6.0 | 25.7% | 18.1% | 25.3% | 13.7% | 10.3% | 1.4% | 4.1% | |
$34.4B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$30.7B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$24.0B | 4.7 | (37.8%) | (45.6%) | (6.7%) | (3.5%) | (6.5%) | 0.8% | 0.0% | |
$14.5B | 5.5 | 14.5% | 9.6% | 37.0% | 12.9% | 6.4% | (2.8%) | 3.6% | |
$13.8B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.3% | |
$13.4B | 6.2 | 11.0% | 3.5% | 15.1% | 7.7% | 5.5% | 1.0% | 0.5% | |
$13.3B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$1,846.9M | 4.3 | (43.2%) | (47.6%) | (43.3%) | (25.3%) | (27.4%) | 1.2% | 0.0% |
FAQ
What is the Ocular Therapeutix, Inc. (OCUL) ROIC (Return on Invested Capital)?
The Ocular Therapeutix, Inc. (OCUL) ROIC is (375.6%), compared to the industry median of ((169.7%)) and the 5-year historical average of (291.4%).
What is the Ocular Therapeutix, Inc. (OCUL) ROIC minus WACC (Weighted Average Cost of Capital)?
The Ocular Therapeutix, Inc. (OCUL) ROIC minus WACC is (386.0%), compared to the industry median of ((172.9%)) and the 5-year historical average of (299.5%).
What is the Ocular Therapeutix, Inc. (OCUL) ROE (Return on Equity)?
The Ocular Therapeutix, Inc. (OCUL) ROE is (58.0%), compared to the industry median of ((41.2%)) and the 5-year historical average of (760.2%).
What is the Ocular Therapeutix, Inc. (OCUL) ROCE (Return on Capital Employed)?
The Ocular Therapeutix, Inc. (OCUL) ROCE is (39.3%), compared to the industry median of ((39.5%)) and the 5-year historical average of (57.6%).